The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers, patients, and the public about a report concerning the circulation of unregistered ViroActive+ Capsules in Nigeria.
This report was received as a complaint in the Bauchi state NAFDAC office. The unregistered ViroActive+ is a drug purported to cure HIV. It is promoted online in Nigeria as a herbal supplement claimed to boost the immune system, treat or cure viral infections, especially HIV, and improve general health.
It is important to note that there is no credible scientific evidence that herbal capsules can cure HIV. HIV is treated with antiretroviral therapy (ART) prescribed by medical professionals.
This product is unregistered, and the ingredients and manufacturing standards are unclear; the safety, quality, and effectiveness have not been verified through clinical trials.
Potential Risks:
Using unverified products like this may lead to treatment failure if patients stop proven HIV medication, unknown side effects or toxicity, delay in proper medical care, and exposure to counterfeit or substandard products.
Product Details:
The Product details of the unregistered product are as follows.
Product name: ViroActive+
Batch Number: GVC/DEC/25/01
Manufacturing Date: 03/12/2025
Expiry Date: 02/12/2027
Product Photo:
All NAFDAC zonal directors and state coordinators have been instructed to conduct surveillance and remove any unregistered products found within their respective zones and states.
Distributors, retailers, healthcare professionals, and caregivers are advised to exercise caution and vigilance throughout the supply chain to prevent the distribution, sale, and use of the product. It is essential to obtain all medical products from authorized and licensed suppliers. Additionally, the authenticity and physical condition of these products should be thoroughly checked.
Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call NAFDAC on 0800-162-3322, or via email: sf.alert@nafdac.gov.ng
Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng, or via the Med- safety application available for download on Android and IOS stores, or via e-mail on pharmacovigilance@nafdac.gov.ng
For complaints, you can call the Reforms Unit on the following lines: 09097630506, 09097630507, or email: reforms@nafdac.gov.ng
Furthermore, note that this notice will be uploaded to the WHO Global Surveillance and Monitoring System (GSMS).
NAFDAC………. Customer-focused, Agency-minded!!!
